We are live on ! Find out more
PCM

Puissance Capital Management Portfolio holdings

AUM $17.3M
1-Year Est. Return 149.36%
This Fund
S&P 500
This Quarter Est. Return
+9.73%
1 Year Est. Return
+149.36%
3 Year Est. Return
+115.5%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$133M
AUM Growth
+$17M
Cap. Flow
+$5.91M
Cap. Flow %
4.44%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
2
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
+$3.29M
2
KDMN
Kadmon Holdings, Inc.
KDMN
+$2.61M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 27.65%
2 Healthcare 21.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRAY
1
DELISTED
ViewRay, Inc.
VRAY
$47.4M 35.62%
6,842,975
– –
CHRN
2
ChronoScale Holdings
CHRN
$2.69B
$36.8M 27.65%
91,266
– –
BLPH
3
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$20.1M 15.1%
553,250
– –
KDMN
4
DELISTED
Kadmon Holdings, Inc.
KDMN
$16.3M 12.29%
4,095,000
+670,000
+20% +$2.61M
TCON
5
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$12.4M 9.35%
23,009
+6,195
+37% +$3.29M

Similar funds

FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
IAM
ICM Asset Management Spokane, Washington $18.1M AUM 30.29% 1-Year Est. Return
FP
FFL Partners San Francisco, California $16.1M AUM 46.91% 1-Year Est. Return
AF
AMG Funds Stamford, Connecticut $20M AUM 3.75% 1-Year Est. Return
TCS
Texas Children's Houston, Texas $20.5M AUM 51.2% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
PCM
Proxima Capital Management New York $21M AUM 3.49% 1-Year Est. Return
NC
Numen Capital London, United Kingdom $13.5M AUM 47.6% 1-Year Est. Return

Puissance Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Puissance Capital Management held 5 positions worth $133M, up 15% from $116M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Puissance Capital Management deployed $5.91M of net new capital in Q2 2018, adding to 2 existing holdings.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare.

  • Puissance Capital Management added most to TRACON Pharmaceuticals, Inc. Common Stock in Q2 2018, an estimated $3.29M increase.
  • Puissance Capital Management's ten largest holdings make up 100% of its $133M portfolio in Q2 2018.
  • Puissance Capital Management opened 0 new positions and closed 0 in Q2 2018.
  • Puissance Capital Management's portfolio value rose 15% quarter-over-quarter to $133M.

Based on Puissance Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.